Sleep Medicine · Nov 2026
Hypoxic Burden Versus Apnea-Hypopnea Index as a Predictor of Cardiovascular Outcomes in Obstructive Sleep Apnea: A Systematic Review
By Mari PV, Siciliano M, Ielo S et al.
Background The apnea–hypopnea index (AHI) remains the metric for grading obstructive sleep apnea (OSA) severity, although its association with cardiovascular (CV) outcomes is inconsistent. Hypoxic burden (HB) integrates the depth and duration of respiratory event-related oxygen desaturations and may better reflect OSA-related physiological stress. We evaluated the association between HB and CV outcomes and its prognostic information relative to AHI. Methods We conducted a systematic review according to PRISMA 2020 recommendations and the Synthesis Without Meta-analysis (SWiM) guideline. PubMed, Web of Science, and the Cochrane Library were searched from inception to August 2026. The primary synthesis included independent cohort-level estimates reporting adjusted hazard ratios (HRs) per 1-standard deviation (SD) increase in HB, which were presented in a forest plot without a pooled estimate and synthesized by direction of effect. Within-study HB and AHI associations were compared descriptively. Results Eleven publications reporting 14 analyses from seven cohorts or trials were included. Four independent cohort-level estimates were available for the primary synthesis. All four indicated higher CV risk with increasing HB (HRs per 1-SD increase 1.13–1.45); the 95% CI excluded the null in three estimates and reached it in the fourth. Given the small number of estimates, these were not pooled. In a descriptive synthesis of eight within-study comparisons, HB showed a significant positive association with CV outcomes, whereas AHI showed no consistent positive association and was inversely associated with CV mortality in one MrOS analysis. In a single post hoc analysis of RICCADSA, high HB was associated with increased MACCE risk even among participants with relatively low AHI. Conclusions Across individual community-based cohorts and populations with established cardiovascular disease and OSA, higher HB was consistently associated with increased CV morbidity and mortality, with modest effect sizes, and may provide prognostic information not fully captured by AHI. Given the small number of independent cohorts and the descriptive nature of the synthesis, these findings should be regarded as hypothesis-generating. These findings support a pathophysiologically informed, multidimensional assessment of OSA severity and CV risk. Prospective studies should standardize HB measurement, establish actionable thresholds, validate incremental prognostic value, and determine whether HB-guided risk stratification improves clinical outcomes.